This innovative technique, carried out in collaboration with the Medical Physics and Radiological Protection service, involves placing implants in the tumor itself so that the linear accelerator can detect them. This allows the machine to precisely know its location and treat it specifically, avoiding irradiation of healthy tissue and increasing patient comfort.
The Synchrony technique enables real-time monitoring of tumor movement, taking into account the patient's natural breathing and locating its position at every moment. The hospital complex has been employing this technique for lung cancer patients since late 2025, with positive results.
In 2025, ablative radiotherapy was applied to 74 cancer patients, and so far in 2026, over 60 patients have been treated for pathologies affecting organs such as the liver, kidney, lung, or bones. Ablative radiotherapy, also known as SBRT (Stereotactic Body Radiotherapy), has been used at the complex since 2016 to treat various types of cancer. It is a non-invasive modality administered in one to five sessions, depending on tumor size and patient clinical characteristics. Since its implementation, more than four hundred people have received treatment using this technique.
Radiation oncology plays an essential role in cancer treatment, as sixty to seventy percent of cancer patients will need radiotherapy at some point, whether for curative purposes, as a complement to surgery or systemic treatments, or for palliative objectives. The service is equipped with four state-of-the-art linear accelerators, among other advanced equipment, and a team of 56 professionals.
During 2025, the service carried out over 19,300 radiation oncology treatments, benefiting nearly 2,000 patients, representing an 18.60 percent increase in the number of treatments administered compared to the previous year.
